
Senator renews scrutiny of pharma ties on federal panel
A high-ranking Senate Democrat is pushing for more answers on why doctors and patient advocates with financial ties to the pharmaceutical industry came to serve on a panel that advises the federal government on pain issues.
Jun 24, 2016
0
10